NASDAQ$NOTV
Inotiv Inc · Q1 2022 earnings
Q1 2022 earnings · · Investor relations
Briefing
Inotiv's Q1 2022 financial results were announced, highlighting significant revenue growth driven by strategic acquisitions and internal expansion.
Inotiv reported a significant increase in revenue for Q1 2022, primarily driven by the acquisition of Envigo and growth in both DSA and RMS segments. The company experienced a substantial rise in total revenue, gross profit, and adjusted EBITDA, but also reported a net loss due to increased operating expenses, including stock compensation and fair value remeasurement of convertible notes.
- Total revenue increased by 370.4% to $84.2 million, driven by DSA and RMS revenue growth.
- DSA revenue increased by $14.9 million due to acquisitions and internal growth.
- RMS revenue reached $51.4 million, primarily from the Envigo acquisition.
- Adjusted EBITDA increased by 621.4% to $10.1 million, representing 12.0% of total revenue.
Headline financials
Revenue & EPS history
Inotiv · Revenue · Quarterly
$84.2M
Revenue by segment
Inotiv · $84.2M total across 2 segments · Q1 2022
- RMS$51.4M—61.0%
- DSA$32.8M—39.0%
Forward guidance
Inotiv anticipates continued revenue growth and margin expansion, driven by strategic acquisitions and internal investments. The company expects to benefit from cross-selling opportunities and a focus on superior client experiences.
Tailwinds
- Strong DSA backlog of $104.6 million indicates robust near-term revenue growth.
- Strategic acquisitions of Plato BioPharma and ILS enhance service offerings.
- Partnership with Synexa Life Sciences strengthens biomarker platform.
- Acquisition of Envigo provides access to critical research models and mitigates supply bottlenecks.
- Investments in G&A support new services and expansion.
Headwinds
- Net loss of $(83.0) million due to stock compensation expense and fair value remeasurement of convertible notes.
- Decrease in gross profit percentage due to lower margins on RMS products.
- Increased operating expenses due to acquisitions and infrastructure build-out.
- Global research model demand outstrips supply, creating potential supply bottlenecks.
- Integration of acquired businesses may present challenges.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2022
+0.4%
Avg return
Earnings day
+3.5%
Avg return
5 days after
+5.6%
Avg return
30 days after
39%
25 / 64 earnings
Positive
+51.3%
Q4 2022
Best reaction
-35.7%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -3.6% | -0.2% | -72.5% | |
| Q1 2026 | -14.3% | -33.3% | -7.1% | |
| Q4 2025 | -6.3% | -9.6% | -42.6% | |
| Q2 2025 | +11.2% | +4.5% | +33.8% | |
| Q1 2025 | -12.9% | -8.9% | -41.8% | |
| Q4 2024 | +0.8% | -2.6% | +7.4% | |
| Q3 2024 | +5.0% | -5.0% | -15.7% | |
| Q2 2024 | +0.9% | -13.2% | -17.0% | |
| Q1 2024 | +15.0% | +45.5% | +126.5% | |
| Q4 2023 | -24.6% | -7.1% | +17.2% | |
| Q3 2023 | -35.7% | -40.7% | -49.0% | |
| Q2 2023 | -7.0% | +0.2% | -13.1% | |
| Q1 2023 | +4.5% | +4.4% | -30.1% | |
| Q4 2022 | +51.3% | +67.4% | +47.4% | |
| Q3 2022 | +24.9% | +33.9% | +16.1% | |
| Q2 2022 | +42.5% | +60.3% | +21.1% | |
| Q1 2022 | -18.7% | -28.8% | -47.9% | |
| Q4 2021 | -13.0% | +9.7% | -19.8% | |
| Q3 2021 | +6.5% | +3.2% | +13.1% | |
| Q2 2021 | +4.2% | +9.3% | +9.6% | |
| Q1 2021 | +25.2% | +34.7% | +48.4% | |
| Q4 2020 | +20.9% | +13.6% | +74.3% | |
| Q3 2020 | -12.8% | -15.7% | -10.6% | |
| Q2 2020 | +6.2% | +13.2% | +25.4% | |
| Q1 2020 | -12.3% | -13.1% | -20.4% | |
| Q4 2019 | +13.7% | +10.8% | +34.5% | |
| Q3 2019 | -4.8% | +16.2% | +73.8% | |
| Q2 2019 | -2.9% | -4.8% | -4.3% | |
| Q1 2019 | -4.9% | -2.1% | +31.9% | |
| Q4 2018 | -2.3% | -2.3% | +6.8% | |
| Q3 2018 | +0.0% | +6.7% | +7.3% | |
| Q2 2018 | +0.6% | -2.3% | -5.2% | |
| Q1 2018 | -19.6% | -16.4% | -15.3% | |
| Q4 2017 | -3.9% | -5.7% | -22.1% | |
| Q3 2017 | -4.0% | -2.8% | -9.7% | |
| Q2 2017 | +6.3% | +3.2% | +5.7% | |
| Q1 2017 | +23.1% | +20.9% | +64.8% | |
| Q4 2016 | +10.0% | -1.2% | +17.5% | |
| Q3 2016 | -13.6% | -4.3% | -18.6% | |
| Q2 2016 | -6.9% | — | — | |
| Q1 2016 | -14.3% | — | — | |
| Q4 2015 | -3.1% | — | — | |
| Q3 2015 | -8.6% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -5.5% | — | — | |
| Q4 2014 | -7.5% | — | — | |
| Q3 2014 | +15.2% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | -9.8% | — | — | |
| Q4 2013 | +9.6% | — | — | |
| Q3 2013 | +25.9% | — | — | |
| Q2 2013 | +9.6% | — | — | |
| Q1 2013 | +3.4% | — | — | |
| Q4 2012 | -5.9% | — | — | |
| Q3 2012 | +4.8% | — | — | |
| Q2 2012 | -7.5% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q1 2011 | +0.0% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q2 2011 | -3.8% | — | — | |
| Q4 2010 | -4.3% | — | — | |
| Q3 2011 | -4.3% | — | — | |
| Q3 2010 | -4.3% | — | — | |
| Q2 2010 | -3.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro